Join to access to all OVN content. Join for Free
How to Create a GREAT MSL Team Culture
Chad Fellers team dynamics in medical affairs team-centric culture fostering development recruiting for cultural fit

How to Create a GREAT MSL Team Culture


Share This Article


Summary

In this episode, Chad Fellers joins to discuss the crucial elements of team dynamics and leadership in medical affairs. Chad shares insights into his background, emphasizing the importance of a team-centric culture and how positive intent in communication extends beyond the workplace. The conversation delves into the significance of trust, fostering development, and recruiting for cultural fit to ensure career satisfaction. Chad also reflects on adapting team culture during the pandemic, offering practical strategies. The episode concludes with a nod to the podcast's mission and encouragement for listener engagement.

Chad Fellers, Director, Medical Science Liaisons at Harmony Biosciences discusses how to develop a GREAT MSL team culture.

Chad shares…

👉 His strategy, philosophy, and key ingredients for a great team culture

👉 Why culture is so important and the benefits of a great culture

👉 Why a “sense of ownership” is so important

👉 How the pandemic and the virtual world affected the team culture

👉 His “Lead vs manage” philosophy and how to cater to the individual team member for career satisfaction

Click for Source
Chad Fellers, team dynamics in medical affairs, team-centric culture, fostering development, recruiting for cultural fit

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Article
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
OVN Avatar Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Explore OVN